rs878854420
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP2PP5_Moderate
The ENST00000275034.5(PHIP):āc.50T>Gā(p.Phe17Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000693 in 1,442,510 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F17S) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000275034.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHIP | NM_017934.7 | c.50T>G | p.Phe17Cys | missense_variant | 2/40 | ENST00000275034.5 | NP_060404.4 | |
PHIP | XM_005248729.6 | c.50T>G | p.Phe17Cys | missense_variant | 2/40 | XP_005248786.1 | ||
PHIP | XM_011535919.2 | c.50T>G | p.Phe17Cys | missense_variant | 2/26 | XP_011534221.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHIP | ENST00000275034.5 | c.50T>G | p.Phe17Cys | missense_variant | 2/40 | 1 | NM_017934.7 | ENSP00000275034 | P3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.93e-7 AC: 1AN: 1442510Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 716076
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.